INDP (Indaptus Therapeutics) Pangali Forward P/E

Logo korporat perusahaan Indaptus (INDP)

The forward P/E NTM of Indaptus Therapeutics (INDP) reflects the valuation dynamics relative to expected earnings, where the current status is 0.00. Indaptus Therapeutics is developing bacterial immuno-oncology, monetizing patents through royalties from pharma behemoths. The business currently lacks stable cash flow, remaining dependent on clinical success. High barriers to entry create stringent filters due to synthesis complexity and FDA requirements.

Prakiraan rega marang bathi: Indaptus Therapeutics, Inc. (INDP) kanggo 04.07.2022 - 12.11.2026

Rincian analitis perusahaan Indaptus Therapeutics

Ringkesan analitik perusahaan:Indaptus Therapeutics, Inc.
Sampel barang Indaptus Therapeutics

The lack of revenue and high clinical trial costs at Indaptus Therapeutics (INDP) create extreme negative operating leverage, complicating a classic valuation. The company's forward P/E ratio compares current market capitalization with expected earnings, allowing investors to determine the degree of optimism priced in regarding future drug commercialization and filter out market noise.

Pesaing Indaptus Therapeutics (INDP)

Prakiraan rega marang bathi ARGX (argenx)|BNTX (BioNTech Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ABVX (abivax.com)|Kapitalisasi marang proyeksi bathi ADMA Corp (ADMA)|PTGX - Rega marang bathi mangsa ngarep|immunovant.com (IMVT) - Prakiraan rega marang bathi|Kiniksa (KNSA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Grifols SA|Prakiraan rega marang bathi ADPT|Pangali Forward P/E Celldex Corp|Rega marang bathi mangsa ngarep Aurinia Pharmaceuticals (AUPH)|biocryst.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Rasio prakiraan rega marang bathi|Pharvaris Corp - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi AbCellera Biologics ABCL|Tourmaline Bio, Inc. (TRML) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep PGEN|PHAR (Pharming Group) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep NKTR (Nektar Therapeutics Inc)|Pangali Forward P/E UPB|Pangali Forward P/E Zenas Corp (ZBIO)|Rega marang bathi mangsa ngarep Immunome, Inc. IMNM|GOSS (gossamerbio.com) - Rasio rega marang bathi sing dikarepake|KALV: Prakiraan rega marang bathi|Septerna, Inc. - Rasio kapitalisasi marang bathi mangsa ngarep|PVLA (Pieris Pharmaceuticals Inc) - Prakiraan rega marang bathi|Savara Pharma (SVRA) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Rigel Pharmaceuticals|anaptysbio.com (ANAB) - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi ATXS (Astria Therapeutics, Inc.)|ENGN (enGene Holdings Inc) - Pangali mangsa ngarep rega marang bathi|RAPT Therapeutics, Inc. - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep JBIO (Aerovate Therapeutics, Inc.)|Aclaris Therapeutics - Pangali Forward P/E|Pangali mangsa ngarep rega marang bathi KYTX (kyvernatx.com)|TLSA: Pangali Forward P/E|Rasio prakiraan rega marang bathi Cabaletta Bio Inc. (CABA)|Rega marang bathi mangsa ngarep Ventyx Bio|THTX: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E AVTX|Pangali Forward P/E eledon.com (ELDN)|Rega marang bathi mangsa ngarep Agenus Inc. AGEN|CLYM (Climb Bio Inc.) - Rasio rega marang bathi sing dikarepake|Zura Bio Limited - Pangali Forward P/E|Rasio prakiraan rega marang bathi aTyr Pharmaceuticals|ADAG (adagene.com) - Prakiraan rega marang bathi|Ikena Oncology (IMA) - Pangali Forward P/E|Prakiraan rega marang bathi STTK|EQ (Equillium Bio) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E CNTB|Kapitalisasi marang proyeksi bathi immunic-therapeutics.com|Pangali Forward P/E ATRA (Atara Bio)|IFRX - Prakiraan rega marang bathi|XFOR - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Adicet Bio ACET|CELU: Pangali Forward P/E|INMB - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Barinthus Biotherapeutics|Rasio rega marang bathi mangsa ngarep KZR (kezarlifesciences.com)|Pangali Forward P/E SABS|Akari Therapeutics PLC - Rasio rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Enlivex Therapeutics Ltd. ENLV|QTTB (Q32 Bio Inc) - Rasio rega marang bathi sing dikarepake|GOVX - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake EDSA|IBIO: Pangali Forward P/E|Carisma Therapeutics Inc. - Pangali mangsa ngarep rega marang bathi|XTLB (XTL Biopharmaceuticals, Ltd.) - Pangali Forward P/E|Pangali Forward P/E Bolt Bio|Rega marang bathi mangsa ngarep HCW Biologics Inc. (HCWB)|APVO (aptevotherapeutics.com) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep AIM ImmunoTech AIM|ADTX - Prakiraan rega marang bathi|GRI Bio Corp - Pangali Forward P/E|XRTX - Pangali Forward P/E|HIND (Vyome Holdings Inc) - Prakiraan rega marang bathi|revbiosciences.com - Pangali mangsa ngarep rega marang bathi|SCNI (Scinai Immunotherapeutics Ltd.) - Pangali Forward P/E|CalciMedica Corp (CALI) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Affimed (AFMD)|Prakiraan rega marang bathi allakos.com ALLK|Rega marang bathi mangsa ngarep HOOKIPA Pharma HOOK|IGMS - Prakiraan rega marang bathi|ITOS: Prakiraan rega marang bathi|OCEA - Pangali Forward P/E|TC BioPharm (Holdings) PLC (TCBP) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep THRD